Note: Read each question carefully and choose the best answer among the choices.
0 of 10 questions completed
Questions:
You have already completed this quiz. You cannot start it again.
Quiz is loading…
You must sign in or sign up to take this quiz.
You must first complete the following:
Quiz complete. Results are being recorded.
0 of 10 questions answered correctly
Your Time:
Time has elapsed.
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Average Score |
|
Your Score |
|
The following are PDE-5 inhibitors and diabetes benefits EXCEPT for:
Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes (choose correct answer):
True or false: A most important question in medical history for midlife and older men: “Do you have normal erectile function?”
Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions (choose incorrect answer):
Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions (choose incorrect answer):
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction.
PDE-5-I can: (choose incorrect answer)
Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis.
We carried out a meta-analysis to assess the effect of PDE-5 inhibitors in patients with left CHF.
Fourteen studies enrolling a total of 928 patients were incorporated in the meta-analysis.
True or false: Among patients with CHF with reduced left ventricular ejection fraction (n = 555), a significant benefit was conferred by PDE-5 inhibitors against the risk of the composite endpoint of death and hospitalizations demonstrated a 72% reduction in serious sequelae!
Phosphodiesterase-5 inhibitors and the heart: Compound cardioprotection?
Better outcomes occur for those who have PDE-5s in their system if they have a heart attack (choose incorrect answer):
Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension (choose incorrect answer):
Nebivolol potentiates the efficacy of PDE-5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway (choose incorrect answer):